3 completed, 2 active not recruiting, 2 recruiting. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Active not recruiting 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow MTBVAC: new trials by email Literature Review of MTBVAC trials Research Report on MTBVAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024) MTBVAC, BCG Sii - Tuberculosis (TB) | Phase 2 | Active not recruiting | Bharat Biotech International Limited | 164 | 2025-03-27 | 2026-04-29 |
| A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region. MTBVAC, Placebo - Tuberculosis (TB) | Phase 2 | Active not recruiting | International AIDS Vaccine Initiative | 5500 | 2025-02-19 | 2026-09-09 |
| Evaluating the Safety and Immunogenicity of MTBVAC MTBVAC, BCG - HIV I Infection, Tuberculosis | Phase 2 | Recruiting | HIV Vaccine Trials Network | 276 | 2024-01-30 | 2026-03-12 |
| Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa MTBVAC, BCG - Tuberculosis | Phase 3 | Recruiting | Biofabri, S.L | 7120 | 2022-10-17 | 2025-02-10 |
| Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates MTBVAC, BCG - Tuberculosis | Phase 2 | Completed | Biofabri, S.L | 99 | 2019-02-12 | 2025-04-27 |
| MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa MTBVAC, BCG - Tuberculosis | Phase 1 / Phase 2 | Completed | International AIDS Vaccine Initiative | 144 | 2018-05-14 | 2023-02-27 |
| Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults MTBVAC, BCG - Tuberculosis | Phase 1 / Phase 2 | Completed | Biofabri, S.L | 54 | 2015-09-01 | 2018-05-01 |
Tuberculosis (7)
Biofabri, S.L (3) · International AIDS Vaccine Initiative (2) · Bharat Biotech International Limited (1) · HIV Vaccine Trials Network (1)
South Africa (6) · India (1) · Kenya (1) · Tanzania (1)
Mark Hatherill (2) · Michele Tameris, MD (2) · Angelique Luabeya, MD (1) · Dr.V.Krishna Mohan, PhD (1) · Limakatso Lebina (1)